Precigen sees Q1 revenue exceeding $18M, consensus $20.8M

1 hour ago 1

TipRanks

Wed, April 8, 2026 astatine 7:02 AM CDT 1 min read

“In the abbreviated clip since aboriginal and afloat approval, the standard-of-care first-line attraction is seeing tremendous progress,” said Precigen’s (PGEN) President and CEO, Helen Sabzevari, during a league telephone to sermon 4th fourth results. “This important advancement constitutes a pivotal milestone for each stakeholders impacted by RRP.” As a effect of the involvement successful PAPZIMEOS, Sabzevari said the institution is transforming from a probe and improvement biopharmaceutical institution to a merchandise gross generating biotech company. Net merchandise income of PAPZIMEOS were $3.4M successful the 4th fourth of 2025, with shipments commencing successful November. In the 4th quarter, Precigen diligent hub enrollment surpassed 300, a testament to doc and diligent demand. Sabzevari noted the institution expects gross successful the archetypal 4th of 2026 to transcend $18M fixed the momentum of PAPZIMEOS. “This is simply a wide motion of the enthusiasm we are seeing from patients and physicians alike, starring to a robust usage of the immunotherapy,” she said.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Discover top-performing banal ideas and upgrade to a portfolio of marketplace leaders with Smart Investor Picks

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected PGEN:

Disclaimer & DisclosureReport an Issue

Precigen sees ‘robust uptake’ successful usage of Papzimeos since its launch
Papzimeos: Accelerating Commercial Ramp, Larger-Than-Expected RRP Market, and Strong 2026 Revenue Outlook Support Buy Rating
Precigen Earnings Call Signals Powerful Launch Momentum
Precigen jumps connected Q1 outlook contempt net miss
Buy Rating connected Papzimeos Driven by Strong Early Launch Traction, Multi‑Year Growth Catalysts, and Long-Term IP Protection

Read Entire Article